PROLONG PHARMACEUTICALS
Prolong Pharmaceuticals, Inc. develops and markets biopharmaceutical products. Its products include PEG-uricase for the treatment of hyperuricemia; PEG-arginase for the treatment of melanoma and hepatocellular carcinoma; PEG-protein for the treatment of hypovolemic shock; PEG-peptide antibiotic to treat staphylococcus infections; PEG-streptokinase for myocardial infarcts; anti-cancer agents; and Erythropoietin, a biopharmaceutical that provides a solution for anemia. The company also offers custom manufacturing services; and licenses its products to pharmaceutical companies. Prolong Pharmaceuticals, Inc. was founded in 2002 and is based in New Jersey.
PROLONG PHARMACEUTICALS
Social Links:
Industry:
Biopharma Biotechnology Pharmaceutical
Founded:
2005-01-01
Address:
South Plainfield, New Jersey, United States
Country:
United States
Website Url:
http://www.prolongpharma.com
Total Employee:
51+
Status:
Active
Contact:
908-444-4660
Email Addresses:
[email protected]
Total Funding:
30 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Euro Apple Mobile Web Clips Icon Google Font API WordPress Font Awesome Mobile Non Scaleable Content Shutterstock
Similar Organizations
Avid Radiopharmaceuticals
Avid Radiopharmaceuticals develops molecular imaging agents for detecting and monitoring chronic human diseases.
Dura Pharmaceuticals
Dura Pharmaceuticals develops prescription pharmaceutical products for the treatment of allergies and asthma.
Jenrin Discovery
Jenrin Discovery is a biopharmaceutical Company.
NephroDI Therapeutics
NephroDI Therapeutics is a biopharmaceutical company that focuses on the concentration disorders of the kidney.
Prestwick Pharmaceuticals
Prestwick Pharmaceuticals develops and markets therapeutic pharmaceutical drugs for chronic central nervous systems diseases.
Founder
Investors List
Tarsadia Investments
Tarsadia Investments investment in Seed Round - Prolong Pharmaceuticals
Official Site Inspections
http://www.prolongpharma.com Semrush global rank: 5.67 M Semrush visits lastest month: 1.44 K
- Host name: aacb0a264e514dd48.awsglobalaccelerator.com
- IP address: 75.2.70.75
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
More informations about "Prolong Pharmaceuticals"
Prolong - About Us
Prolong Pharmaceuticals, LLC does not provide any drug in development to patients unless they have been accepted into one of our ongoing clinical trials. For more information on our โฆSee details»
Meet Our Team: Industry Leaders in Stroke Treatment - Prolong โฆ
Our leadership team has driven success in multiple pharmaceutical and biotechnology companies. Prolongโs founders invented PEGylation, a breakthrough drug delivery technology โฆSee details»
Prolong Pharmaceuticals - Crunchbase Company Profile & Funding
Prolong Pharmaceuticals, Inc. develops and markets biopharmaceutical products. Its products include PEG-uricase for the treatment of hyperuricemia; PEG-arginase for the treatment of โฆSee details»
Prolong Pharmaceuticals, LLC. - Overview, News & Similar
Explore Complete Organization Structure. Is Prolong Pharmaceuticals, LLC. your ideal customer? ... (908) 444-4660 Website: www.prolongpharma.com What does Prolong Pharmaceuticals, โฆSee details»
Prolong Pharmaceuticals, LLC - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Prolong Pharmaceuticals, LLC of South Plainfield, NJ. Get the latest business insights from Dun & โฆSee details»
Prolong Pharmaceuticals - PitchBook
Information on valuation, funding, cap tables, investors, and executives for Prolong Pharmaceuticals. Use the PitchBook Platform to explore the full profile.See details»
Prolong Pharmaceuticals - Craft
Prolong Pharmaceuticals has 5 employees at their 1 location and $30 m in total funding,. See insights on Prolong Pharmaceuticals including office locations, competitors, revenue, โฆSee details»
Prolong Pharmaceuticals Company Profile -Sales, Contacts, โฆ
Prolong Pharmaceuticals is in the Pharmaceuticals industry within the Wholesale Trade - Nondurable Goods sector and has been in business for approximately 19 years.See details»
Prolong Pharmaceuticals - Employees, Contact info, Overview - Wiza
Apr 30, 2024 View info about Prolong Pharmaceuticals (prolongpharma.com). Prolong Pharmaceuticals is a company located in South Plainfield, New Jersey, United States. Find โฆSee details»
Prolong
Prolong Pharmaceuticals, LLC does not provide any drug in development to patients unless they have been accepted into one of our ongoing clinical trials. For more information on our โฆSee details»
Prolong Pharmaceuticals LLC - Drug pipelines, Patents ... - Patsnap
Www.prolongpharma.com. Holding Company | 2005 | New Jersey, United States | 50-100 | www.prolongpharma.com. Last update 01 Nov 2024. Overview. Pipeline. Deal. Translational โฆSee details»
Prolong Pharmaceuticals - Products, Competitors, Financials, โฆ
Headquarters Location. 1 Cragwood Road Suite 203. South Plainfield, New Jersey, 07080, United States. 908-444-4660See details»
Prolong Pharmaceuticals Overview | SignalHire Company Profile
Organization Website. prolongpharma.com . Prolong Pharmaceuticals industries. Pharma Headquarters Location. 300B Corporate Court, South Plainfield, New Jersey, 07080 US. โฆSee details»
Prolong Pharmaceuticals Information - RocketReach
Prolongpharma.com; 2 908820XXXX; 732651XXXX; Judson Sagers Associate Director, Accounting at Prolong Pharmaceuticals Bedminster Township, NJ, US View. 1 โฆSee details»
Prolong Pharmaceuticals LLC (Prolong Pharmaceuticals LLC) - ่ฏ็ฉ โฆ
For more information visit: . View source version on businesswire.com: Contacts Ronald Jubin, Ph.D. Vice President, Early Development Prolong Pharmaceuticals Ph: (908) 315-5762 โฆSee details»
Prolong Pharmaceuticals CEO and Key Executive Team - Craft
Prolong Pharmaceuticals's President is Nikunj Patel. Other executives include Ron Jubin, Vice President, R&D; John Pakulski, Senior Vice President, Regulatory. See the full leadership โฆSee details»
Prolong Pharmaceuticals Company Overview, Contact Details
Oct 14, 2010 Prolongpharma attends event 2025 International Stroke Conference. Prolong Pharmaceuticals to present preliminary Phase 1 data from HEMERA-1 for PP-007 in Acute โฆSee details»
Prolong
Our leadership team has driven success in multiple pharmaceutical and biotechnology companies. Prolongโs founders invented PEGylation, a breakthrough drug delivery technology โฆSee details»
Prolong Pharmaceuticals - Tarsadia
Prolong Pharmaceuticals is a clinical-stage biopharmaceutical company focused on identifying, developing, and commercializing differentiated products that address unmet medical needs. โฆSee details»
Prolong - Resources
Prolong Pharmaceuticals, LLC does not provide any drug in development to patients unless they have been accepted into one of our ongoing clinical trials. For more information on our โฆSee details»